Home>Topics>Stocks>Alexion Pharmaceuticals

Alexion Pharmaceuticals ALXN

  1. All
  2. Commentary
  3. Headlines
    1. From Barron’s, August 11, 2014 (Part 1)


      Sat, 9 Aug 2014

      politicians. But that alone won’t stop inversions and possible future candidates with 45% or more revenues from overseas include ALXN , IPG, JCI, OI, MON . For the week , Dow +0.37% , SP500 +0.33% , Nasdaq Comp +0.42% , Russell 2000 +1.48

    2. Alexion Reports Strong 1Q Results and Again Increases Guidance; Raising Fair Value


      Thu, 24 Apr 2014

      guidance for 2014 of $4.75-4.85 (from $4.37-$4.47) was significantly above our expectations of $4.45. While ALXN maintained its revenue guidance of $2.15-$2.17 billion, profitability improvements are driven by guidance for cost of

    3. From Barron’s, March 31, 2014 (Part 2)


      Sat, 29 Mar 2014

      market performance relative to sectors such as IT that require lesser capex. Some highflyers sank last week, e.g. biotechs [ ALXN , CELG, GILD, REGN ] and other momentum favorites [ GMCR, FB, TWTR, P, YELP, NFLX, BIDU ]; fears of higher rates and

    4. Medalist Funds Like These Large-Cap Stocks


      Wed, 12 Feb 2014

      FOXA 24 45 Media-Diversified Union Pacific UNP 23 23 Railroads LinkedIn LNKD 22 94 Internet Content & Info Alexion Pharmaceuticals ALXN 21 71 Biotech Amgen AMGN 21 22 Biotech Costco COST 21 44 Discount Stores Microsoft MSFT 21 3 Software-Infrastructure

    5. Which Funds Own My Stock?


      Tue, 21 Jan 2014

      companies that are at least 50% owned by mutual funds brings up a different list that includes companies such as Alexion Pharmaceuticals ALXN , Chipotle Mexican Grill CMG, Illumina ILMN, Lululemon Athletica LULU, and Moody's MCO. The fact that

    6. Alexion shares rise after report of approach by Roche


      Tue, 30 Jul 2013

      (Reuters) - Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last...

    7. Alexion's Soliris On Track to Meet Our Expectations for 2013


      Fri, 26 Jul 2013

      Alexion ALXN reported second-quarter results that put it on track to meet our expectations for the full year, and we're maintaining our

    8. Alexion Reports Another Period of Stellar Soliris Growth; Late-Stage Pipeline Opportunities Progress


      Thu, 25 Apr 2013

      Alexion Pharmaceuticals ' ALXN first-quarter results saw another period of eye-popping growth for rare-disease drug Soliris. The firm's updated guidance

    9. Hedge fund manager Kris Jenner


      Wed, 10 Apr 2013

      information is related,” Leonard Bell, chief executive officer of Cheshire, Connecticut- based Alexion Pharmaceuticals Inc. ( ALXN ), said in an interview. Jenner held Alexion shares for more than a decade. T. Rowe Price was Alexion

    10. Soliris Hits Blockbuster Status in 2012 and Positions Alexion for Further Margin Expansion in 2013


      Thu, 14 Feb 2013

      Alexion ALXN reported very strong fourth-quarter results that reflected continued steady growth of Soliris in its primary PNH indication, as

    « Prev12345Next »
    Content Partners